BSE - Free Realtime Quote INR

Shilpa Medicare Limited (SHILPAMED.BO)

975.90
+10.70
+(1.11%)
As of 12:28:35 PM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
12,864,141
12,864,141
11,516,030
10,434,464
11,400,492
Cost of Revenue
4,103,707
4,103,707
4,075,539
4,168,439
3,840,982
Gross Profit
8,760,434
8,760,434
7,440,491
6,266,025
7,559,510
Operating Expense
6,719,841
6,719,841
6,074,219
6,311,992
6,301,200
Operating Income
2,040,593
2,040,593
1,366,272
-45,967
1,258,310
Net Non Operating Interest Income Expense
-755,329
-755,329
-918,094
-568,914
-389,225
Pretax Income
1,223,329
1,223,329
543,407
-382,794
1,022,648
Tax Provision
440,361
440,361
223,855
-73,066
416,827
Net Income Common Stockholders
782,929
782,929
318,742
-325,332
606,623
Diluted NI Available to Com Stockholders
782,929
782,929
318,742
-325,332
606,623
Basic EPS
8.04
8.04
3.67
-3.75
7.26
Diluted EPS
8.04
8.04
3.67
-3.75
7.26
Basic Average Shares
97,379.23
97,379.23
86,850.68
86,801.90
83,535.73
Diluted Average Shares
97,379.23
97,379.23
86,850.68
86,801.90
83,535.73
Rent Expense Supplemental
--
--
12,536
10,095
11,594
Total Expenses
10,823,548
10,823,548
10,149,758
10,480,431
10,142,182
Net Income from Continuing & Discontinued Operation
782,930
782,930
318,743
-325,332
606,623
Normalized Income
962,659.55
962,659.55
275,828.10
-316,694.60
594,256.80
Interest Income
--
--
13,841
17,607
20,666
Interest Expense
755,329
755,329
918,094
562,547
409,338
Net Interest Income
-755,329
-755,329
-918,094
-568,914
-389,225
EBIT
1,978,658
1,978,658
1,461,501
179,753
1,431,986
EBITDA
3,108,583
3,108,583
2,540,200
1,134,743
2,230,005
Reconciled Cost of Revenue
4,103,707
4,103,707
4,075,539
4,168,439
3,840,982
Reconciled Depreciation
1,129,925
1,129,925
1,078,699
954,990
798,019
Net Income from Continuing Operation Net Minority Interest
782,930
782,930
318,743
-325,332
606,623
Total Unusual Items Excluding Goodwill
-280,814
-280,814
61,307
-10,675
17,666
Total Unusual Items
-280,814
-280,814
61,307
-10,675
17,666
Normalized EBITDA
3,389,397
3,389,397
2,478,893
1,145,418
2,212,339
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-101,084.45
-101,084.45
18,392.10
-2,037.60
5,299.80
3/31/2022 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VENUSREM.BO Venus Remedies Limited
464.00
+4.62%
 
WANBURY.BO Wanbury Limited
314.30
+4.99%
 
ANUHPHR.BO Anuh Pharma Limited
215.05
-0.07%
 
INDSWFTLTD.NS Ind-Swift Limited
17.47
-3.59%
 
IOLCP.BO IOL Chemicals and Pharmaceuticals Limited
88.98
-1.37%
 
SEQUENT.BO Sequent Scientific Limited
195.15
+0.44%
 
SIGACHI.BO Sigachi Industries Limited
57.92
+0.84%
 
NECLIFE.NS Nectar Lifesciences Limited
23.60
-1.09%
 
DIVISLAB.BO Divi's Laboratories Limited
6,685.00
-0.56%
 
WOCKPHARMA.BO Wockhardt Limited
1,750.95
-1.84%